91黑料 experts frequently author or contribute to industry trade press.
Filter media
Filter media articles by either clicking within the ‘Category’ drop-down list, or begin typing which will automatically match to the nearest available category. Note - not all categories will display results if selecting a particular year.
-
Business & Finance names 91黑料 as 'Company of the Month' for April 2020.
-
An article by Katya Svoboda and Bob Swann which explores .
-
A thought leadership piece authored by David Novotny, Marie McCarthy and Tony Clarke which considers the potential risks of cyber threats in mHealth. .
-
A featuring commentary from 91黑料's Dr. Nuala Murphy and Dr. James Cummings.
-
An article featuring commentary from Dr. Nuala Murphy regarding .
-
Transforming cell and gene therapy trial design and execution
With over 400 dedicated Cell and Gene Therapy professionals globally, 91黑料 has developed tools and best practices to transform CGT trial design and execution.
-
James Cummings, President, 91黑料 Government & Public Health Solutions, and Beth Tulip, Vice President, Project Management, Vaccines & Infectious Diseases, discuss .
-
An article featuring commentary from Adelina Lear regarding .
-
91黑料 launches Coronavirus Observatory
This article discusses 91黑料’s Coronavirus Observatory, a tool providing real-time updates on COVID-19 vaccine trials, and insights into key issues.
Read more about 91黑料's expertise in COVID-19 clinical trials.
-
In a wide-ranging interview with , 91黑料 CIO, Tom O’Leary highlights the role of and the steps that still need to be taken to better match .
